2018
DOI: 10.1016/j.annemergmed.2017.09.031
|View full text |Cite
|
Sign up to set email alerts
|

A Randomized, Double-Blind, Placebo-Controlled Trial of Naproxen With or Without Orphenadrine or Methocarbamol for Acute Low Back Pain

Abstract: Among ED patients with acute, nontraumatic, nonradicular low back pain, combining naproxen with either orphenadrine or methocarbamol did not improve functional outcomes compared with naproxen+placebo.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
35
0
2

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 53 publications
(40 citation statements)
references
References 19 publications
1
35
0
2
Order By: Relevance
“…In one study, patients were randomized to treatment with 7 days of naproxen + diazepam or naproxen + placebo (June 2015–February 2016). In the other study, patients were randomized to treatment with 7 days of naproxen + placebo, naproxen + orphenadrine, or naproxen + methocarbamol (March 2016–February 2017) . The study protocols were identical, with the exception of slightly different exclusion criteria, which were necessary because of slightly different contraindications to investigational medications.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…In one study, patients were randomized to treatment with 7 days of naproxen + diazepam or naproxen + placebo (June 2015–February 2016). In the other study, patients were randomized to treatment with 7 days of naproxen + placebo, naproxen + orphenadrine, or naproxen + methocarbamol (March 2016–February 2017) . The study protocols were identical, with the exception of slightly different exclusion criteria, which were necessary because of slightly different contraindications to investigational medications.…”
Section: Methodsmentioning
confidence: 99%
“…Low back pain (LBP) causes more than 2.5 million visits to U.S. emergency departments (EDs) annually . Among the subset of ED patients who present with acute LBP, most will recover, although 10% to 20% of this group report moderate or severe LBP 3 months later and 30% report LBP‐related functional impairment . These patients are at risk for chronic LBP, a debilitating, highly prevalent condition that erodes quality of life and accounts for more than $600 billion in direct and indirect costs annually .…”
mentioning
confidence: 99%
“…NSAIDs are efficacious, though only modestly, and are frequently accompanied by adverse medication effects . Adding oxycodone, diazepam, or skeletal muscle relaxants to NSAIDs does not result in improved outcomes. Generally, with the passage of time, most patients who present to an ED with acute, nonradicular LBP improve.…”
Section: Discussionmentioning
confidence: 99%
“…4 It is not yet clear if combination therapy with more than one medication can improve LBP outcomes. For a general population of patients with acute, nonradicular LBP, combining NSAIDs with oxycodone, 3 diazepam, 5 or skeletal muscle relaxants 6,7 does not improve 1-week outcome more than treatment with NSAIDs alone. Acetaminophen is often used for acute LBP, although it is unlikely to be effective when used as monotherapy.…”
mentioning
confidence: 95%
“…There is growing interest and research that supports the use of nonpharmacologic strategies, such as superficial heat, massage, acupuncture, spinal manipulation, or noncontrolled substance pharmacologic treatments such as nonsteroidal anti-inflammatory drug (NSAID) medications or muscle relaxants as first-line therapies. [42][43][44][45][46][47] This is echoed in the 2017 American College of Physicians (ACP) guidelines. 48 These guidelines differ from the 2007 guidelines in that acetaminophen is no longer recommended as a first-line therapy for acute muscular and radicular pain.…”
Section: Treatment Of Muscular and Radicular Painmentioning
confidence: 99%